BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 04/08/2025

FDA Clears Heparin Sodium Products for Approval of Abbreviated New Drug Applications

The FDA has determined that three Heparin Sodium products were not withdrawn from sale due to safety or effectiveness concerns, paving the way for the approval of abbreviated new drug applications for these products.

Source: Federal Register — Food and Drug AdministrationOpen original release →